Advanz Limits Takeda Patent Team's Access To Biosimilar Info
By Jamie Lennox ( July 31, 2026, 5:42 PM BST) -- A London judge restricted the activities of two in-house lawyers at Takeda on Friday to ensure they don't use Advanz's confidential information for purposes that fall outside their ongoing bowel disease drug patent clash....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.